Automation index
How much of a Immunologist’s job can AI already do?
An autoantibody panel comes earlier. Calling it autoimmune without leaving the patient untreated do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Immunologist
27%
AI can already do 27% of this job.
#168 / 643
View rankingImmunologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Panel, autoantibodies and the report.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Clinic, the flare and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Immunosuppressant, the dose and not dropping extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Infection, the risk and vaccinating on time.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The internist, the board and not delaying the biologic.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Call it autoimmune, and sign the treatment.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- autoantibodies
- autoimmune flares
- immunosuppressants
- biologics
- vaccinate the immunocompromised
- immunology clinic
- opportunistic infections
- immune panels
Sources for this job· O*NET 29-1229.00· ESCO/ISCO 2212
IS WORK OVER?
Clinical research associate
27%
#172 / 643
View rankingClinical research associate
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Protocol, CRF and the monitoring visit.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Source, the gap and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Adverse event, the deadline and not delaying.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Consent, the signature and the one who did not understand.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The sponsor, the audit and not dressing the figure.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Audit, and not leaving a made-up figure.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- CRF
- monitoring
- adverse events
- informed consent
- source data
- trial audits
- clinical protocols
- site visits
Sources for this job· O*NET 11-9121.00· ESCO/ISCO 2131